Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2006-01-17
2008-10-21
Stucker, Jeffrey (Department: 1649)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C514S002600, C435S069100, C435S007100, C435S371000, C435S366000, C435S320100
Reexamination Certificate
active
07439327
ABSTRACT:
The invention relates to pharmaceutical compositions comprising gastrointestinal proliferative factor SCFA2, SCFA4 or SCFA4vpolynucleotides and polypeptides. The invention further relates to the therapeutic use of SCFA2, SCFA4 or SCFA4vto prevent or treat conditions or disorders associated with the degeneration of the epithelial mucosa.
REFERENCES:
patent: 2005/0054829 (2005-03-01), Wiley et al.
patent: 2005/0169995 (2005-08-01), Kuo et al.
patent: 2007/0059829 (2007-03-01), Yoon
patent: 1440981 (2004-07-01), None
patent: WO 03020932 (2003-03-01), None
patent: WO 03/029405 (2003-04-01), None
patent: WO 2005/040418 (2005-05-01), None
patent: WO 2005/110009 (2005-11-01), None
Wells, 1990, Biochemistry 29:8509-8517.
Ngo et al., 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Bork, 2000, Genome Research 10:398-400.
Skolnick et al., 2000, Trends in Biotech. 18(1):34-39.
Doerks et al., 1998, Trends in Genetics 14:248-250.
Smith et al., 1997, Nature Biotechnology 15:1222-1223.
Brenner, 1999, Trends in Genetics 15:132-133.
Bork et al., 1996, Trends in Genetics 12:425-427.
Altschul, S.F., et al., “Basic Local Alignment Search Tool,”J. Mol. Biol.215:403-410 (1990).
Altschul, S.F., “A Protein Alignment Scoring System Sensitive at All Evolutionary Distances,”J. Mol. Evol.36:290-300 (1993).
Berthrong, M., “Pathologic Changes Secondary to Radiation,”World J. Surg.10:155-170 (1986).
Bouma, G. and Strober, W., “The Immunological and Genetic Basis of Inflammatory Bowel Disease,”Nature Rev.3:521-533 (2003).
Boushey, R.P., et al., “Glucagon-like Peptide (GLP)-2 Reduces Chemotherapy-associated Mortality and Enhances Cell Survival in Cells Expressing a Transfected GLP-2 Receptor,”Cancer Res.61:687-693 (2001).
DiBaise, J.K., et al., “Intestinal Rehabilitation and the Short Bowel Syndrome: Part 2,”Am. J. Gastroenterol.99:1823-1832 (2004).
Farrell, C.L., et al., “The Effects of Keratinocyte Growth Factor in Preclinical Models of Mucositis,”Cell Prolif.35(Suppl. 1):78-85 (2002).
Garnier, A., et al., “Scale-up of the Adenovirus Expression System for the Production of Recombinant Protein in Human 293S Cells,”Cytotechnology15:145-155 (1994).
Guzman-Stein, G., et al., “Abdominal Radiation Causes Bacterial Translocation,”J. Surg. Res.46:104-107 (1989).
Han, D.S., et al., “Keratinocyte Growth Factor-2 (FGF-10) Promotes Healing of Experimental Small Intestinal Ulceration in Rats,”Am. J. Gastrointest. Liver Physiol.279:G1011-G1022 (2000).
Helmrath, M.A., et al., “Intestinal Adaptation Following Massive Small Bowel Resection in the Mouse,”J. Am. Coll. Surg.183:441-449 (1996).
Jeffers, M., et al., “A Novel Human Fibroblast Growth Factor Treats Experimental Intestinal Inflammation,”Gastroenterology123:1151-1162 (2002).
Kazanskaya, O., et al., “R-Spondin2 Is a Secreted Activator of Wnt/β-Catenin Signaling and Is Required forXenopusMyogenesis,”Dev. Cell7:525-534 (2004).
Kilpeläinen, I., et al., “Heparin-binding Growth-associated Molecule Contains Two Heparin-binding β-sheet Domains That Are Homologous to the Thrombospondin Type I Repeat,”J. Biol. Chem.275:13564-13570 (2000).
Krieglstein, C.F., et al., “Collagen-binding Integrin α1β1Regulates Intestinal Inflammation in Experimental Colitis,”J. Clin. Invest.110:1773-1782 (2002).
L'Heureux, M-C. and Brubaker, P.L., “Glucagon-like Peptide-2 and Common Therapeutics in a Murine Model of Ulcerative Colitis,”J. Pharmacol. Exp. Ther.306:347-354 (2003).
Lawler, J., “The Functions of Thrombospondin-1 and -2,”Curr. Opin. Cell Biol.12:634-640 (2000).
Long, M.W. and Dixit, V.M., “Thrombospondin Functions as a Cytoadhesion Molecule for Human Hematopoietic Progenitor Cells,”Blood75:2311-2318 (1990).
McGinley, J.N., et al., “Effect of Fixation and Epitope Retrieval on BrdU Indices in Mammary Carcinomas,” J. Histochem. Cytochem. 48:355-362 (2000).
Moore, J.V., “Clonogenic Response of Cells of Murine Intestinal Crypts to 12 Cytotoxic Drugs,”Cancer Chemother. Pharmacol.15:11015 (1985).
Neurath, M.F., et al., “Antibodies to Interleukin 12 Abrogate Established Experimental Colitis in Mice,”J. Exp. Med.182:1281-1290 (1995).
Neilsen, H., et al., “A Neural Network Method for Identification of Prokaryotic and Eukaryotic Signal Peptides and Prediction of Their Cleavage Sites,”Int. J. Neural Syst.8:581-599 (1997).
Potten, C.S., et al., “Cell Kinetic Studies in the Murine Ventral Tongue Epithelium: Mucositis Induced by Radiation and Its Protection by Pretreatment with Keratinocyte Growth Factor (KGF),”Cell Prolif.35(Suppl 1):32-47 (2002).
Raz, E., et al., “Interallelic Complementation Among DER/flbAlleles: Implications for the Mechanism of Signal Transduction by Receptor-Tyrosine Kinases,”Genetics129:191-201 (1991).
Scholzen, T. and Gerdes, J., “The Ki-67 Protein: From the Known and the Unknown,”J. Cell Physiol.182:311-322 (2000).
Scott, R.B., et al., “GLP-2 Augments the Adaptive Response to Massive Intestinal Resection in Rat,”Am. J. Physiol.275:G911-G921 (1998).
Siegmund, B., et al., “Adenosine Kinase Inhibitor GP515 Improves Experimental Colitis in Mice,”J. Pharmacol. Exp. Ther.296:99-105 (2001).
Sonis, S.T., et al., “An Animal Model for Mucositis Induced by Cancer Chemotherapy,”Oral Surg. Oral Med. Oral Pathol.69:437-443 (1990).
Sonnhammer, E.L.L., et al., “Pfam: Multiple Sequence Alignments and HMM-profiles of Protein Domains,”Nucl. Acids Res.26:320-322 (1998).
Wardley, A.M., et al., “A Quantitative Histometric Murine in vivo Model of Radiation-Induced Oral Mucositis,”Arch. Oral Biol.43:567-577 (1998).
Whitehead, R.H., et al., “Clonogenic Growth of Epithelial Cells from Normal Colonic Mucosa From Both Mice and Humans,”Gastroenterology117:858-865 (1999).
Withers, H.R. and Elkind, M.M., “Microcolony Survival Assay for Cells of Mouse Intestinal Mucosa Exposed to Radiation,”Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med.17:261-267 (1970).
Zhou, A., et al., “Proteolytic Processing in the Secretory Pathway,”J. Biol. Chem.274:20745-20748 (1999).
Database Geneseq [Online], EBI Accession No. GSP:ABR62106, “Secreted Stem Cell Growth Factor-Like Protein #13,” (2003).
Kamata, et al., “R-Spondin, A Novel Gene with Thrombospondin Type 1 Domain, was Expressed in the Dorsal Neural Tube and Affected in Wnts Mutants,”Biochim Biophys Acta1676(1):51-62 (2004).
Kim, et al., “R-Spondin Proteins: A Novel Link to Beta—Catenin Activation,”Cell Cycle5(1):23-26 (2006).
Database EPO Proteins [Online], EBI Accession No. EPOP:CQ843580, “Sequence 2227 from Patent EP1440981,” (2004).
Database Geneseq [Online], EBI Accession No. GSP:ADY56840, “Human Thrombospondin-30b (1-198) Protein Fragment,” (2005).
Boyle Bryan J.
Emtage Peter C. R.
Funk Walter
Tang Y. Tom
Zhao Jingsong
Dutt Aditi
Nuvelo, Inc.
Robins & Pasternak LLP
Stucker Jeffrey
LandOfFree
Stem cell factor-like proteins and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stem cell factor-like proteins and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stem cell factor-like proteins and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3990632